Category: Washington Post

  • Skillet miso cod with warm slaw brims with protein, fiber, and flavor

    Everyone seems to be zoomed in on protein these days, but while protein is important, I suggest an expanded nutritional perspective. Instead of focusing on that one nutrient, consider a meal’s PFD — protein, fiber, and deliciousness. The acronym works, because together, these three elements provide the broader nourishment needed to ride life’s waves and to maximize the pleasure in doing it.

    This skillet recipe offers easily ample PFD in about 30 minutes. The protein is meaty fillets of cod, which also bring health-protective omega-3 fats and essential minerals to the plate. (Alternatively, any thick, steak-like fillet will work, such as salmon, halibut, or sea bass.) The fillets get nestled into a barely softened sauté of shredded cabbage, carrots, onion, and ginger. (You can slice the cabbage and carrots yourself, or use a package of slaw mix as a shortcut.) The vegetables introduce the gut-friendly fiber factor, plus a wealth of antioxidants, vitamins, and minerals.

    A mixture of miso paste, softened butter, and a touch of honey, slathered on the fish and dolloped on the vegetables, amplify the deliciousness of these already-tasty ingredients. Add a little water to the pan and a brightening drizzle of rice vinegar, cover it, and let the resulting steam cook the fish until it’s flaky, the vegetables relax into a warm slaw, and everything is imbued with the savory-sweet richness of the miso butter.

    Sprinkled with fresh scallions and served with rice, if you’d like, it’s a meal that can save a busy weeknight all the while maximizing nutrition.

    Skillet Cod With Miso Butter and Warm Slaw

    An umami-rich mixture of miso paste, butter, and honey imbues this saucy skillet cod and warm, gingery slaw with savory-sweet flavor. It’s quick to prepare as written, but can be made even faster by subbing the cabbage and carrots with a bagged slaw mix.

    4 servings

    Total time: 30 minutes

    Storage: Refrigerate for up to 2 days.

    Ingredients

    3 1/2 tablespoons shiro (white) miso

    2 tablespoons unsalted butter, softened

    1 tablespoon honey

    4 (6-ounce) center-cut cod fillets, patted dry

    1 tablespoon neutral oil, such as avocado or canola

    1 medium yellow onion (8 ounces), halved and thinly sliced

    1 (1-inch) piece fresh ginger, peeled and sliced into thin matchsticks (about 1 tablespoon)

    5 cups (9 ounces) lightly packed thinly sliced green cabbage

    2 medium carrots, sliced into ribbons using a vegetable peeler

    1/3 cup water

    1 tablespoon unseasoned rice vinegar

    1/4 teaspoon freshly ground black pepper

    2 scallions, thinly sliced

    cooked rice, for serving (optional)

    Steps

    In a small bowl, combine the miso, butter, and honey, and mash with a fork until well incorporated.

    Spread a scant 1 tablespoon of the miso mixture on top of each cod fillet.

    In a large (12-inch) skillet over medium heat, heat the oil until shimmering. Add the onion and ginger, and cook, stirring occasionally, until the onion starts to soften, about 2 minutes. Add the cabbage and carrots, and cook, stirring frequently, until slightly softened, about 2 minutes more.

    Arrange the fish, miso side up, on top of the vegetables. Scatter small dollops of the remaining miso mixture over the vegetables in the pan. In a liquid measuring cup, combine the water with the rice vinegar, then drizzle the mixture over the vegetables in the pan, taking care to avoid the fish. Cover and cook until the fish is just cooked through, 6 to 8 minutes, depending on the thickness of the fish, and adjust the heat as needed to maintain a steady, but not overly strong, steam.

    Transfer the fish to a cutting board or large plate. Stir the vegetables to coat them in the sauce and season with the pepper.

    Divide the warm slaw among plates or shallow bowls. Top each portion with the fish, garnish with the scallions, and serve warm, with rice on the side, if desired.

    Substitutions: Cod >> other firm fish, such as halibut or salmon. Sliced cabbage and carrots >> one 12-ounce bag slaw mix. Rice vinegar >> apple cider vinegar. Honey >> maple syrup or agave. Yellow onion >> white onion. Scallions >> chopped flat-leaf parsley leaves.

    Gluten-free? Be sure to seek out gluten-free miso.

    Nutrition | Per serving (1 fish fillet and 1/2 cup vegetables): 318 calories, 22g carbohydrates, 88mg cholesterol, 11g fat, 5g fiber, 33g protein, 4g saturated fat, 599mg sodium, 12g sugar

    This analysis is an estimate based on available ingredients and this preparation. It should not substitute for a dietitian’s or nutritionist’s advice.

    From cookbook author and registered dietitian nutritionist Ellie Krieger.

  • Google unveils quantum computing breakthrough on Willow chip

    Google unveils quantum computing breakthrough on Willow chip

    Alphabet Inc.’s Google ran an algorithm on its “Willow” quantum-computing chip that can be repeated on similar platforms and outperform classical supercomputers, a breakthrough it said clears a path for useful applications of quantum technology within five years.

    The “Quantum Echoes” algorithm, detailed in a paper published Wednesday in the science journal Nature, is verifiable, meaning it can be repeated on another quantum computer. It also ran 13,000 times faster than previously possible on the world’s best supercomputer, Google said. Taken together, the advances point to a broad range of potential uses in medicine and materials science, Google said.

    “The key thing about verifiability is it’s a huge step in the path toward a real world application,” said Tom O’Brien, a staff research scientist at Google Quantum AI who oversaw the completion of this work. “In achieving this result we’re really pushing us toward finding mainstream.”

    Alphabet shares rose as much as 2.4% Wednesday in New York trading before closing up 0.5%.

    The breakthrough brings Google a step closer to harnessing the processing power promised by quantum computing, also being pursued by rivals Microsoft Corp., International Business Machines Corp., and numerous start-ups. It follows Google’s announcement in December that Willow had solved a problem in five minutes that would have taken a supercomputer 10 septillion years.

    Quantum computers use tiny circuits to perform calculations, like traditional computers do, but they make these calculations in parallel, rather than sequentially, making them much faster. While firms have boasted of building quantum platforms that surpass classical computers, their challenge has been to find a useful application.

    Computer scientist Scott Aaronson, who wasn’t involved in the study, wrote in an email that he was “thrilled” by Google’s progress toward outperforming supercomputers in a way which could be efficiently repeated, and thus proved, on a second quantum computer — which had been “one of the biggest challenges of the field for the past several years.” Still, he warned that there was a lot of work ahead.

    “Getting from here to anything commercially useful, and/or to scalable fault-tolerance (which wasn’t used for this demonstration), will be additional big challenges,” wrote Aaronson, who serves as the Schlumberger Centennial Chair of computer science at the University of Texas at Austin.

    The Google team, which includes 2025 Nobel Prize in Physics winner Michel H. Devoret, said it plans to continue to move toward real-world applications by scaling up and improving the accuracy of its machines.

  • 4 vaccines that are linked to a lower risk of dementia

    4 vaccines that are linked to a lower risk of dementia

    Vaccines don’t just protect us from infectious diseases or lessen their effects. Some are also associated with a reduced risk for dementia, research shows.

    “They’ll protect against these really potentially severe infections, especially in older adults, and preventing that alone is huge,” said Avram Bukhbinder, a resident physician at Massachusetts General Hospital in Boston who has conducted research on vaccines and dementia risk.

    “There seems to also be some kind of added benefit and ultimately it just adds a more compelling reason” to get routine vaccines, he said.

    Studies have found that many vaccines may be associated with a reduced risk of dementia — here are four of the most common ones with the strongest links.

    The flu shot

    An estimated 47 million to 82 million people in the United States — about 13 to 24% of all people — caught influenza, or the flu, during the 2024-2025 season with 27,000 to 130,000 Americans dying as a result, according to preliminary data from the Centers for Disease Control and Prevention. (Flu season generally runs from October to May in North America.)

    Influenza and pneumonia — a potential complication of flu — are associated with five neurodegenerative diseases, including dementia and Parkinson’s disease, according to a 2023 study analyzing biobank data from over 400,000 people.

    “I don’t know how many times in the adult world we hear, ‘My loved one got flu, was in the hospital for a week or two, and it just was never the same.’ Like quickly went downhill from there,” Bukhbinder said.

    Many studies have found that flu vaccination is associated with a lower risk of dementia years later.

    In a 2022 study, Bukhbinder and his colleagues at the University of Texas Health Science Center at Houston examined a large health database of over 1.8 million adults ages 65 and over. They found that those who received at least one flu vaccine were 40% less likely to develop Alzheimer’s — the most common form of dementia — during the next four years.

    Getting the flu vaccine was also associated with a 17% reduction in dementia risk in a 2024 study of over 70,000 participants.

    The CDC recommends all people over 6 months old get annual flu shots, typically in September or October.

    Fewer than half of Americans typically get their flu vaccine each season.

    The shingles vaccine

    The shingles vaccine has the strongest evidence for reducing the risk of dementia with multiple large-scale studies in the past two years corroborating the results of older studies.

    In one 2025 study, researchers tracked more than 280,000 adults in Wales and found that the shingles vaccine was linked with reducing dementia risk by 20% over a seven-year period.

    “There may be potential additional benefits beyond the protection that the vaccine provides for a particular condition,” said Pascal Geldsetzer, an assistant professor of medicine at the Stanford University School of Medicine and the senior author of the study. “So, that’s only an additional reason to get vaccinated.”

    A subsequent study examining over 100,000 patients in Australia similarly found that getting vaccinated for shingles was associated with reduced dementia risk.

    If you are eligible, you should probably get a shingles vaccine regardless of its chances of reducing your dementia risk. The vaccine reduces the reactivation of the varicella-zoster virus, which causes chickenpox in childhood and remains dormant in nerve cells afterward. When reactivated in adulthood, the virus manifests as shingles, which is characterized by a burning, painful rash and can sometimes cause lifelong chronic pain conditions or serious complications in a subset of people who get it.

    The CDC recommends two doses of a shingles vaccine for adults 50 and older or those 19 and older with a weakened immune system; 36% of eligible Americans got vaccinated in 2022.

    The RSV vaccine

    Respiratory syncytial virus, or RSV, is a common respiratory virus that can cause mild, coldlike symptoms in most people, but may cause severe infections in children as well as adults ages 65 and older. (The virus is the leading cause of hospitalization among American infants and causes an estimated 100 to 300 deaths in children under 5, and 6,000 to 10,000 deaths in people 65 or older, every year in the U.S.)

    The FDA approved the first RSV vaccine in 2023.

    A recent study tracking over 430,000 people found that the RSV vaccine (as well as the shingles vaccine) was associated with a reduced risk of dementia over 18 months compared with those who received the flu vaccine.

    The CDC recommends all adults ages 75 and older, as well as adults older than 50 at higher risk of RSV, get the vaccine.

    The Tdap vaccine

    Several studies have reported that the vaccine against tetanus, diphtheria, and pertussis (or whooping cough), or Tdap, is associated with a reduced risk of dementia.

    One 2021 study with over 200,000 patients reported that older adults who received both the shingles and Tdap vaccines had further reduced risk of dementia compared with those who only received one of the vaccines.

    The CDC recommends routine Tdap vaccination for all adolescents and a booster for adults every 10 years. In 2022, about 30% of adults ages 19-64 who could be assessed had received a Tdap vaccine.

    How vaccines may reduce dementia risk

    Research has shown that severe infections, including flu, herpes, and respiratory tract infections, are linked to accelerated brain atrophy and increased risk of dementia years down the line.

    “We think it’s the uncontrolled kind of systemic inflammation that’s probably contributing to that,” Bukhbinder said. “And it’s very likely that they had the underlying Alzheimer’s or other dementia pathology already, but the inflammation is what pushed them over the edge.”

    Geldsetzer said that the varicella-zoster virus, which causes shingles, has the most clear biological links because it hibernates in our nervous system and can more directly affect the brain. (Getting a chickenpox vaccine in childhood can prevent this virus from taking hold in the first place.)

    Though different vaccines are linked to reduced dementia risk, there are inherent limitations to how the research was conducted. The link is associational, not causal, because the people who get vaccines may be different from those who don’t.

    For example, it could be that “those who are on average more health-motivated, have better health behaviors, are the ones who decide to get vaccinated,” Geldsetzer said. Even though researchers try to account for these confounding variables, it is not possible to fully filter out differences in health behaviors associated with dementia risk.

    But recent studies hint at a stronger link between the shingles vaccine and dementia-risk reduction. This research takes advantage of “natural experiments” because of arbitrary dates that the governments of Wales and Australia set for shingles vaccine eligibility; those born immediately before and after the eligibility date are probably not different and can be more directly compared. And when they are, those who got the shingles vaccines had lower risk of dementia, said Geldsetzer, who was an author on the Wales and Australia studies and is raising money to fund a randomized controlled trial.

    There are two broad biological hypotheses for how vaccines are linked to reduced dementia risk. Vaccines could reduce the risk of getting sick and infection severity, which have been linked to increased dementia risk.

    “I feel confident that that’s part of the story, but it’s not the whole story,” Bukhbinder said.

    Another, not mutually exclusive possibility is that the vaccine itself may activate the immune system in a beneficial way. Vaccination “may be honing or refining the immune system’s response,” Bukhbinder said.

    There’s “good evidence that what happens outside of the brain … seems to actually affect the inside pretty robustly,” Bukhbinder said.

    How to keep up-to-date on vaccines and reduce dementia risk

    Vaccinations, like all medical treatments, can have some risks and side effects, so it is important to speak with your doctor about your particular health needs.

    However, “I would say by and far the benefits of getting these vaccinations almost incomparably outweigh the risks,” Bukhbinder said.

    In addition, 45% of dementia cases could be delayed or prevented with lifestyle and environmental changes, according to the 2024 Lancet Commission report on dementia.

    To cut dementia risk and lengthen our cognitive health spans, research suggests steps such as changing lifestyle habits, staying socially connected, moderating alcohol intake, maintaining a healthy blood pressure, and addressing hearing loss (such as with hearing aids).

  • Health insurance sticker shock begins as shutdown battle over subsidies rages

    Health insurance sticker shock begins as shutdown battle over subsidies rages

    Millions of Americans are already seeing their health insurance costs soar for 2026 as Congress remains deadlocked over extending covid-era subsidies for premiums.

    The bitter fight sparked a government shutdown at the start of October. Democrats refuse to vote on government-funding legislation unless it extends the subsidies, while Republicans insist on separate negotiations after reopening the government. Now lawmakers face greater pressure to act as Americans who buy insurance through the Affordable Care Act are seeing, or about to see, the consequences of enhanced subsidies expiring at the end of the year.

    Healthcare.gov — the federal website used by 28 states — is expected to post plan offerings early next week ahead of the start of open enrollment in November. But window shopping has already begun in most of the 22 states that run their own marketplaces, offering a preview of the sticker shock to come.

    Premiums nationwide are set to rise by 18 percent on average, according to an analysis of preliminary rate filings by the nonpartisan health policy group KFF. That, combined with the loss of extra subsidies, have left Americans with the worst year-over-year price hikes in the 12 years since the marketplaces launched.

    Nationally, the average marketplace consumer will pay $1,904 in annual premiums next year, up from $888 in 2025, according to KFF.

    The situation is particularly acute in Georgia, which recorded the second-highest enrollment of any state-run marketplace this year and posted prices for 2026 earlier in October. About 96 percent of marketplace enrollees in Georgia received subsidies this year, according to the Center on Budget and Policy Priorities, a liberal think tank that supports extending the subsidies.

    Now Georgians browsing the state website are seeing estimated monthly costs double or even triple, depending on their incomes, as lower subsidy thresholds resume.

    “We have people saying they will have to choose between their monthly premiums and mortgage,” said Natasha Taylor, deputy director of Georgia Watch, a consumer advocacy group.

    For example, a family of four earning $82,000 a year in Georgia could see their annual premium double to around $7,000 for a plan with midrange coverage, according to a CBPP analysis. If that family earned at least $130,000, they would have to pay the full cost of the annual premium, about $24,000 instead of $11,000.

    It’s a similar story in other states, where people in higher income tiers will see especially big premium increases as they become ineligible for subsidies. A 60-year-old couple earning $85,000 may have to pay $31,000 for a plan in Kentucky, $28,000 for a plan in Oregon and $44,000 for a plan in Vermont, according to CBPP.

    If Congress doesn’t extend the extra subsidies, Georgia could lose around 340,000 people from its 1.5 million-person marketplace, according to an estimate by nonpartisan advocacy group Georgians for a Healthy Future.

    The enhanced subsidies had fully covered monthly premiums for millions of lower-income people in the marketplaces. Many of them will have to start kicking in some of their own money starting Jan. 1, while people with higher incomes will see their monthly subsidies shrink. People earning more than 400 percent of the federal poverty line will no longer be eligible for subsidies at all.

    The political fallout in Georgia has already begun to reverberate. Rep. Marjorie Taylor Greene (R-Georgia) broke with her party to demand an extension of subsidies, noting her adult children’s premiums are set to double. Greene’s office didn’t respond to a request for comment.

    Sen. Jon Ossoff, considered the most vulnerable Democratic incumbent in next year’s midterms, has seized on the issue of rising premiums. An Ossoff spokesman said the senator wants the subsidies extended, pointing to polling showing a majority of Georgians feel the same.

    Republican Gov. Brian Kemp, who championed the state’s marketplace, didn’t respond to a request for comment.

    Atlanta resident Jody Fieulleteau, 31, said she has been paying $160 a month for a subsidized plan on Georgia’s marketplace. She makes about $40,000 a year styling hair and providing behavioral therapy. She has yet to complete an application to see quotes for plans next year, but her monthly premium is likely to nearly double based on her age, income and Zip code.

    Fieulleteau said she rushed to schedule a surgery next week for a problem related to menstruation because she’s concerned about having insurance.

    “I’m feeling like I need to get everything done this year because I don’t know what next year is going to look like,” she said in a phone interview.

    Taylor, of Georgia Watch, said she finds that consumers often don’t understand that their plans are subsidized, which makes it difficult to explain that the pricey plans they see now could become cheaper if Congress votes to extend the subsidies.

    “For your average consumer, they look at the bottom line. What’s my out-of-pocket max,” Taylor said. “I don’t think they’re looking at the minutiae of why their premium is what it is.”

    The rising insurance costs highlight the political difficulties faced by Washington lawmakers.

    The Congressional Budget Office, the legislature’s nonpartisan bookkeeper, has estimated nearly 4 million fewer people will have marketplace plans a decade from now if the extra subsidies expire.

    Republicans say the premium assistance — intended to help people be insured during the coronavirus pandemic — are just a Band-Aid for a failure of the Affordable Care Act to rein in the costs of plans. They also say the subsidies were so generous they incentivized fraud, pointing to a CBO estimate that 2.3 million enrollees improperly claimed a subsidy this year.

    But 13 House Republicans who face competitive reelection campaigns next year wrote to House Speaker Mike Johnson (R-Louisiana) on Tuesday asking him to consider extending premium assistance.

    “Millions of Americans are facing drastic premium increases due to shortsighted Democratic policymaking,” they wrote. “While we did not create this crisis, we now have both the responsibility and the opportunity to address it.”

    Sen. Patty Murray (D-Washington) said in a news conference that she heard from families whose premiums are doubling as window shopping started in her state Tuesday. She said she heard similar stories from Idaho and Montana, noting most people who rely on premium assistance live in red states.

    “Families are logging on, looking for health coverage for next year, and coming face to face with massive price hikes because Republicans downright refuse to work with us to do something about it,” Murray said.

    Insurers have partially blamed the premium hikes on the expiration of the subsidies, saying they’ll cause healthy people to drop coverage, leaving a sicker, more expensive pool of customers behind. Insurers have also cited higher drug and hospital prices, expensive weight-loss drugs and medical inflation as reasons for raising premiums.

    But if Congress acts to extend the subsidies, even after open enrollment begins Nov. 1, some plans may be willing to lower premiums, said David Merritt, senior vice president of external affairs at the Blue Cross Blue Shield Association, whose member plans are sold in all marketplaces. Adjusting rates lower would get more complicated after Dec. 31, he said.

    Even if Congress does extend the subsidies, consumer advocates say damage has already been done.

    Many people will visit the insurance marketplaces and decide to forgo coverage after seeing pricey 2026 plans, they said, and not revisit their decision even if subsidies are restored.

  • U.S. finance ban takes effect after already crippling Mexico firms

    U.S. finance ban takes effect after already crippling Mexico firms

    An unprecedented order by the U.S. Treasury to cut off three Mexican financial firms for allegedly helping drug cartels launder funds takes effect Monday. But its impact has already swept through the country’s banking industry.

    The three designated firms — CIBanco SA, Intercam Banco SA, and Vector Casa de Bolsa SA — have been broken up and sold for parts. Their clients have decamped with their business — a big chunk of which was foreign exchange — to other banks or brokerages.

    And beyond those firms, the banking system at large is on high alert: Lenders have purged clients, bolstered internal controls, and upped communication with both Mexican and U.S. regulators in an effort to avoid becoming the next example of the Trump administration’s crackdown on drug cartels.

    U.S. officials have made their intentions clear: There’s a zero-tolerance policy when it comes to helping traffickers launder funds connected to America’s fentanyl crisis. The ban on the three firms — announced in June — was the first use of powers given to the Treasury’s Financial Crimes Enforcement Network by last year’s Fend Off Fentanyl Act. High-level Treasury officials have repeatedly visited the country to hammer home the message.

    “This was a shot across the bow in terms of telling banks that Treasury has this tool and intends to use it,” said Craig Timm, a former Department of Justice lawyer and senior director at the Association of Certified Anti-Money Laundering Specialists. “You don’t want to be next, because as we’re seeing with these institutions, it’s an existential threat the moment it becomes public.”

    Among the order’s knock-on effects: Kapital Bank is acquiring a significant part of Intercam’s operations while Vector has transferred some assets and clients to Casa de Bolsa Finamex SAB.

    CIBanco had its banking license revoked earlier this month and BanCoppel, part of Grupo Coppel, is buying the firm’s portfolio of auto loans. Banco Multiva SA is taking over CIBanco’s trustee business — an operation of substantial importance in Mexico’s financial system. CIBanco was trustee for most of the country’s issuances of private equity certificates and real estate investment trusts. Intercam also had a significant trustee business.

    While the U.S. order had downplayed the potential impact on the Mexico banking system and economy, saying that CIBanco and Intercam together represented less than 2% of the country’s commercial bank assets, it made no mention of the significant size of CIBanco’s trustee offering.

    In the wake of the order, Mexican real estate trusts and U.S. private equity firms had rushed to change trustees in investment vehicles to avoid potentially running afoul of the U.S. designation.

    Unconventional arsenal

    The FinCEN orders are among the Trump administration’s unconventional arsenal of tools it has been deploying both domestically and abroad, such as the recent deadly military strikes on alleged drug-trafficking boats from Venezuela.

    The move against the Mexican banks was part of a broader U.S. administration strategy for the “total elimination of cartels” using powerful tools with a relatively low bar for action. There was no recourse to the order by FinCEN, and just last week Mexican President Claudia Sheinbaum said the U.S. had not delivered convincing evidence that linked the firms to drug trafficking. She said Mexican regulators found only administrative faults and “nothing to do with money laundering.” The banks were fined in late June, in tandem with the U.S. orders, by local regulators over anti-money laundering controls while Vector faced fines related to updating fund information.

    Amid the deeper clampdown by U.S. officials, banks in Mexico and globally are enhancing their scrutiny of transactions, particularly those involving Chinese companies that could be linked to the trade in precursor chemicals, Timm said.

  • White House hits road block in effort to get top colleges to sign deal

    White House hits road block in effort to get top colleges to sign deal

    Despite strong pressure from the Trump administration, including a call with the White House on Friday, colleges and universities are largely rejecting the president’s offer of preferential treatment for funding in exchange for compliance with his ideological priorities.

    Six of nine universities offered the deal earlier this month had publicly said no to the White House request by Monday’s deadline.

    The administration has said it is seeking to make sure the country’s schools are merit-based, but many universities and higher education advocates said the White House’s proposed agreement would undermine the merit-based process currently utilized to award research grants.

    The “Compact for Academic Excellence in Higher Education” is a new attempt by the administration to get schools to eliminate diversity, equity and inclusion policies and ensure more conservative viewpoints and values are integrated into campus life.

    The Trump administration offered it to nine colleges earlier this month, casting it as a means to gain competitive advantage for federal and philanthropic benefits and invitations to White House events in return for what the administration described as compliance with civil rights law and “pursuing Federal priorities with vigor.”

    The ideological tension was reflected during a call on Friday, which the White House organized and presented as a chance to workshop the terms of the compact in partnership with colleges and universities that had not yet responded, according to a person close to the situation, who spoke on the condition of anonymity because of the sensitivity of the matter.

    From the Trump administration, Education Secretary Linda McMahon; White House Domestic Policy Director Vincent Haley, Special Assistant Eric Bledsoe and adviser May Mailman; Josh Gruenbaum of the General Services Administration; and billionaire Marc Rowan were on the call, the person said.

    But within a day of the call, University of Virginia and Dartmouth College rejected the compact, joining ranks with MIT, Brown University, the University of Pennsylvania and the University of Southern California. The University of Texas at Austin was invited to sign on and the chair of the University of Texas System Board of Regents expressed enthusiasm. The University of Arizona and Vanderbilt University have not publicly responded.

    Echoing a term that has been often used by the Trump administration, U-Va.’s president said the agreement violated the merit-based nature of the competition for federal research funding. The federal government currently awards billions of dollars in research grants based on peer reviews and scientific merit.

    On Saturday, Dartmouth President Sian Beilock wrote to McMahon, Mailman and Haley that she welcomed further engagement on enhancing the partnership between the federal government and research universities and ensuring that higher education “stays focused on academic excellence.” But, she wrote, “I do not believe that the involvement of the government through a compact-whether it is a Republican- or Democratic-led White House-is the right way to focus America’s leading colleges and universities on their teaching and research mission.”

    White House spokeswoman Liz Huston described the Friday call as “productive.”

    “The Administration hosted a productive call with several university leaders. They now have the baton to consider, discuss, and propose meaningful reforms, including their form and implementation, to ensure college campuses serve as laboratories of American greatness,” Huston said in a statement. “These leaders are working steadfastly to improve higher education and have been invited to the table to share ideas with the Administration, and we look forward to discussing transparent ways that, together, we will produce future generations of American excellence.”

    A White House official, speaking anonymously to discuss private conversations, said universities will not lose their federal funding because they decided not to engage in the compact.

    The sweeping terms of the compact called on schools to adopt the administration’s priorities, including pledging to freeze tuition for five years, cap international enrollment at 15 percent of a college’s undergraduate student body, and bar the consideration of factors such as gender, race and political views in admissions and other areas.

    Some legal scholars said the terms were unconstitutional. Trump administration officials have insisted they are protecting free speech by compelling universities to reject a culture that suppresses far-right thought.

    Officials asked for “limited, targeted feedback” in writing no later than Oct. 20, with hopes of a signed agreement by Nov. 21.

    As schools turned it down, citing similar concerns – Christina H. Paxson, Brown’s president, wrote in a letter to the White House that provisions in the compact restricting the university’s academic freedom and institutional autonomy would impede its mission – the Trump administration invited more universities to participate. Washington University in St. Louis, the University of Kansas and Arizona State University joined Friday’s call.

    In a Monday statement, Washington University Chancellor Andrew Martin said he had not endorsed or signed on to the compact but agreed to discuss it with the Trump administration. “We believe it is in the best interest of our university, and higher education more broadly, for us to participate constructively, share our experience and expertise, and help inform policies that strengthen the nation’s research and education ecosystem,” Martin said.

    Some of the wording in the compact is vague. But the magnitude of the stakes is clear: The Trump administration has frozen billions of dollars of federal research funding at multiple colleges that it has accused of violating federal civil rights laws for issues such as having diversity, equity and inclusion policies and allegedly not doing enough to prevent antisemitism.

    At Harvard University, which has filed two lawsuits to fight the government’s actions, the administration has tried to bar international students and scholars from campus, threatened to revoke the university’s tax-exempt status and has begun an effort to block the school from receiving any federal grants.

    Faculty, alumni and students at many of the nine schools urged university leaders not to sign. Rallies against the compact occurred on multiple campuses, and student leaders from seven of the nine original schools issued a joint statement opposing it. More than 30 higher education associations issued a statement of opposition Friday, saying “the conditions it outlines run counter to the interests of institutions, students, scholars, and the nation itself.” A coalition formed of alumni groups opposed to the compact.

    President Donald Trump wrote on social media that the administration would continue efforts to swiftly enforce federal law at universities that “continue to illegally discriminate based on Race or Sex,” but that “those Institutions that want to quickly return to the pursuit of Truth and Achievement” were “invited to enter into a forward looking Agreement with the Federal Government to help bring about the Golden Age of Academic Excellence in Higher Education.”

  • Trump’s Venezuelan drug boats claims obscure reality, officials and locals say

    Trump’s Venezuelan drug boats claims obscure reality, officials and locals say

    MEXICO CITY – The Trump administration’s justification for blowing up suspected drug traffickers off the Venezuelan coast has been clear and consistent: These people aren’t just criminals; they’re “narco-terrorists” smuggling a “deadly weapon poisoning Americans” at the behest of terrorist organizations.

    “We take them out,” Trump told the nation’s three- and four-star generals and admirals last month. “Every boat kills 25,000 on average – some people say more. You see these boats, they’re stacked up with bags of white powder that’s mostly fentanyl and other drugs, too.”

    Claiming the power to summarily kill traffickers as though they’re enemy troops, Trump has authorized the U.S. military to strike at least six speedboats the administration has deemed suspicious, killing dozens of people since the beginning of September. At least half of the strikes and 21 of the killings, locals say, have transpired in the waters between Venezuela and Trinidad and Tobago – nations so close that on clear days they’re within eyesight of each other.

    But records and interviews with 20 people familiar with the route or the strikes, including current and former U.S. and international officials, contradict the administration’s claims. The passage, they said, is not ordinarily used to traffic synthetic opioids such as fentanyl, present in 69 percent of drug overdose deaths last year. Nor are the drugs typically headed for the United States.

    Trinidad and Tobago, a Caribbean nation more than 1,000 miles south and 1,200 miles east of Miami, is both a destination market for marijuana and a transshipment point for South American cocaine bound for West Africa and Europe, according to U.S. officials, Trinidadian police and independent analysts. The fentanyl seized in the United States, in contrast, is typically manufactured in Mexico using precursors from China and smuggled in through the land border, most often by U.S. citizens.

    The military strikes are unlikely, as a result, to cut overdose deaths in the United States, officials say – but it has brought U.S. forces into striking distance of Venezuelan President Nicolás Maduro. Trump has accused the authoritarian socialist, who claimed reelection last year despite ballot audits showing he lost the vote, of leading the Venezuela gang Tren de Aragua to push lethal drugs into America.

    “When I saw [an internal document on the strikes],” a senior U.S. national security official said, “I immediately thought, ‘This isn’t about terrorists. This is about Venezuela and regime change.’ But there was no information about what it was really about.”

    The official, like others quoted in this report, spoke on the condition of anonymity to provide his candid assessment.

    The White House declined to share evidence to support the claims that Trump has used to justify the strikes. A spokeswoman defended the killings as necessary to protect Americans.

    “All of these decisive strikes have been against designated narco-terrorists bringing deadly poison to our shores,” spokeswoman Anna Kelly said. “The president will continue to use every element of American power to stop drugs from flooding into our country and to bring those responsible to justice.”

    Two family members of the 11 men killed in September in the first attack acknowledged by Trump did not deny that the men aboard had been taking marijuana and cocaine from Venezuela to Trinidad. But they said Trump’s allegation in his announcement was inaccurate that they’d worked for the Venezuelan gang Tren de Aragua.

    “I knew them all,” said one of the family members, who spoke on the condition of anonymity for fear of retribution. “None of them had anything to do with Tren de Aragua. They were fishermen who were looking for a better life” by smuggling contraband.

    On Tuesday, Trump said, a new strike had killed “six male narco-terrorists” off the Venezuelan coast. That afternoon, one mother in the Trinidadian community of Las Cuevas received a call from her brother, a fisherman. Her son Chad Joseph, the second of her six children, had been killed in the explosion.

    Speaking by phone Thursday morning, Leonore Burnley was furious. Her son had been deprived a trial. And she’d been deprived of any chance of closure.

    “You can’t get the body to bury it,” she said.

    Joseph had spent the last three months in Venezuela working odd jobs, Burnley said. He had written her recently to say he would be returning home.

    She called Trump’s claim he had been involved in trafficking drugs a lie.

    “They are judging him wrong,” she said. “He was no drug dealer. Chad was a good boy, anything you want, he would help; he was a loving child.”

    “Twenty-six years he have,” she said.

    Claiming the power to summarily kill traffickers as though they’re enemy troops, Trump has authorized the U.S. military to strike at least six speedboats the administration has deemed suspicious, killing dozens of people since the beginning of September.

    How cocaine courses through Venezuela

    In recent years, drug cartels in Colombia and other South American nations have supercharged cocaine production. The rush to bring it to market – largely the United States and Europe, but increasingly West Africa – has transformed the continent’s criminal landscape, fueling the rise of new transnational gangs and threatening weaker national governments with limited power of state.

    Venezuela, too, has been swept into the boom. Economically battered by years of socialist mismanagement and punishing international sanctions, a nation that was once Latin America’s wealthiest has become increasingly involved in the trade. Along its border with Colombia, cocaine is now produced for sale and shipment abroad.

    U.S. federal prosecutors in March 2020 accused senior government officials in the Maduro regime, including Maduro himself, of leading the Cártel de Los Soles – “Cartel of the Suns” – a criminal network that extorts drug trafficking groups and controls routes and product itself.

    Venezuela, U.S. investigators say, is now a narco free-for-all filled with armed groups from throughout Latin America.

    “The Mexicans are there,” one former Drug Enforcement Administration agent said. “The Colombians are there, sometimes on behalf of the Mexicans. Sometimes the Hondurans and Guatemalans have guys there, too.”

    Most of the South American cocaine bound for North America flows through the Pacific, but some does depart Venezuela through the Caribbean, according to U.S. officials and analysts who track drug routes. Much of it courses overland through the western states of Zulia and Falcón before shipping northward to Puerto Rico, the U.S. Virgin Islands and the Dominican Republic. Some travels by air, departing clandestine airstrips in Maracaibo or Apure state for Central America and onward to Mexico and the United States.

    It’s less common, investigators say, to ship U.S.-bound cocaine northeast into the Sucre peninsula and across the narrow Bocas del Dragón channel to Trinidad – the route the administration has targeted. Trinidad is used far more frequently as a gateway to Europe. Spanish authorities seized 1.65 tons of cocaine that had transited through the island, the State Department reported in 2024. Portuguese authorities in June recovered 1.66 tons of cocaine that traversed the same route.

    “When you look at a map, countries like Trinidad and Tobago and Suriname are used as transshipment points of massive amounts of cocaine from Colombia into Venezuela [and then onward] to West Africa and Europe,” a former senior U.S. security official said. He added that routes may change based on pressure.

    One recently retired senior Trinidadian police official, asked whether Sucre traffickers were bringing drugs intended for the United States, chuckled.

    “Why would they use Trinidad and Tobago to transport drugs to the United States, when you have Colombia and Mexico and all of these other places that are closer?”

    The waters between Sucre and Trinidad

    The Sucre peninsula, known for its paradisiacal beaches and green-thatched mountains, has always been poor. But its fortunes turned decidedly for the worse in recent years, as the economy melted down and the state slipped into lawlessness.

    With few opportunities to work, fishermen turned to the smuggling route that has long tethered Sucre to Trinidad, a half-hour boat ride away.

    The former senior Trinidadian police official has investigated the route since 1989. It has historically carried many kinds of contraband: guns, cigarettes, alcohol, honey, exotic animals and people. But in recent years, as more drugs poured into Venezuela, it began to be used as a route to bring over marijuana and cocaine.

    “It’s 80 percent marijuana,” said one Trinidad criminologist who has studied seizure data. “Cocaine is a much, much smaller amount.”

    While Tren de Aragua has had a presence in Sucre, locals and drug trafficking analysts say it doesn’t control the trade. The drugs are instead moved by other local gangs.

    “We have found no links between Tren de Aragua and multinational smugglers,” said Jeremy McDermott, co-founder of Insight Crime, whose team recently visited the region. “There was an attempt by them to penetrate Sucre, but they were ejected by local gangs.”

    “The evidence,” he added, “does not support the claims” by the Trump administration.

    One man who grew up in San Juan de Unare along the Sucre coast, but moved to Caracas after his community plunged into poverty, said his cousin Reibys Gomez was among the first fishermen to take drugs to Trinidad. He said his cousin had a young family to support.

    “People are in need,” he said. “They live off fishing and hunting, and that’s it.”

    Now Reibys is dead, and the man said his family has “deteriorated” in San Juan de Unare – unable to collect his body and haunted by questions over why the U.S. military killed him.

    “They were going to Trinidad,” he said. “They weren’t going to the United States.”